Geneos Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $917 | Hold |
5
| – | – | ﹤0.01% | 2417 |
|
|
2025
Q4 | $880 | Sell |
5
-24
| -83% | -$3.92K | ﹤0.01% | 2418 |
|
|
2025
Q3 | $4.06K | Sell |
29
-50
| -63% | -$6.76K | ﹤0.01% | 2191 |
|
|
2025
Q2 | $9.92K | Sell |
79
-113
| -59% | -$14.1K | ﹤0.01% | 2333 |
|
|
2025
Q1 | $26.3K | Buy |
192
+104
| +118% | +$14.9K | ﹤0.01% | 2218 |
|
|
2024
Q4 | $13.5K | Sell |
88
-9
| -9% | -$1.52K | ﹤0.01% | 1920 |
|
|
2024
Q3 | $18.8K | Sell |
97
-137
| -59% | -$28.7K | ﹤0.01% | 1581 |
|
|
2024
Q2 | $54.2K | Sell |
234
-7
| -3% | -$1.52K | ﹤0.01% | 1042 |
|
|
2024
Q1 | $52K | Sell |
241
-109
| -31% | -$25.5K | ﹤0.01% | 1051 |
|
|
2023
Q4 | $90.6K | Hold |
350
| – | – | ﹤0.01% | 867 |
|
|
2023
Q3 | $90K | Sell |
350
-80
| -19% | -$21.4K | ﹤0.01% | 902 |
|
|
2023
Q2 | $122K | Buy |
430
+200
| +87% | +$59.5K | 0.01% | 825 |
|
|
2023
Q1 | $63.9K | Hold |
230
| – | – | ﹤0.01% | 997 |
|
|
2022
Q4 | $63.7K | Sell |
230
-55
| -19% | -$15.5K | ﹤0.01% | 964 |
|
|
2022
Q3 | $76K | Sell |
285
-1,150
| -80% | -$244K | 0.01% | 878 |
|
|
2022
Q2 | $302K | Sell |
1,435
-1
| -0.1% | -$204 | 0.01% | 619 |
|
|
2022
Q1 | $302K | Sell |
1,436
-274
| -16% | -$59.6K | 0.01% | 667 |
|
|
2021
Q4 | $410K | Buy |
1,710
+114
| +7% | +$29.3K | 0.02% | 643 |
|
|
2021
Q3 | $453K | Buy |
1,596
+187
| +13% | +$61.3K | 0.02% | 595 |
|
|
2021
Q2 | $491K | Sell |
1,409
-2,179
| -61% | -$660K | 0.02% | 566 |
|
|
2021
Q1 | $959K | Sell |
3,588
-269
| -7% | -$72.5K | 0.03% | 432 |
|
|
2020
Q4 | $1.03M | Buy |
3,857
+2,578
| +202% | +$665K | 0.04% | 339 |
|
|
2020
Q3 | $349K | Sell |
1,279
-25
| -2% | -$6.97K | 0.02% | 519 |
|
|
2020
Q2 | $337K | Buy |
1,304
+86
| +7% | +$25.9K | 0.02% | 513 |
|
|
2020
Q1 | $361K | Sell |
1,218
-183
| -13% | -$55.5K | 0.02% | 441 |
|
|
2019
Q4 | $420K | Buy |
1,401
+183
| +15% | +$50.8K | 0.02% | 482 |
|
|
2019
Q3 | $280K | Sell |
1,218
-920
| -43% | -$214K | 0.02% | 550 |
|
|
2019
Q2 | $500K | Buy |
2,138
+12
| +0.6% | +$2.77K | 0.03% | 404 |
|
|
2019
Q1 | $502K | Sell |
2,126
-9
| -0.4% | -$2.83K | 0.03% | 392 |
|
|
2018
Q4 | $626K | Sell |
2,135
-11
| -0.5% | -$3.51K | 0.05% | 329 |
|
|
2018
Q3 | $758K | Buy |
2,146
+221
| +11% | +$76.1K | 0.05% | 306 |
|
|
2018
Q2 | $558K | Sell |
1,925
-271
| -12% | -$76.2K | 0.04% | 310 |
|
|
2018
Q1 | $601K | Sell |
2,196
-103
| -4% | -$32K | 0.05% | 276 |
|
|
2017
Q4 | $732K | Sell |
2,299
-50
| -2% | -$16K | 0.07% | 259 |
|
|
2017
Q3 | $735K | Buy |
2,349
+44
| +2% | +$13K | 0.07% | 240 |
|
|
2017
Q2 | $625K | Buy |
2,305
+33
| +1% | +$8.73K | 0.06% | 254 |
|
|
2017
Q1 | $621K | Sell |
2,272
-197
| -8% | -$55.7K | 0.06% | 233 |
|
|
2016
Q4 | $700K | Buy |
2,469
+96
| +4% | +$28.5K | 0.09% | 202 |
|
|
2016
Q3 | $742K | Sell |
2,373
-17
| -0.7% | -$5.04K | 0.1% | 196 |
|
|
2016
Q2 | $585K | Hold |
2,390
| – | – | 0.08% | 219 |
|
|
2016
Q1 | $622K | Buy |
+2,390
| New | +$631K | 0.1% | 205 |
|
Other funds holding BIIB
VCM
VPM
Geneos Wealth Management's BIIB Position: Q1 2026 in Review
Geneos Wealth Management held its Biogen (BIIB) position steady in Q1 2026 at 5 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #2417.
Geneos Wealth Management first reported a position in BIIB in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.03M in Q4 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Geneos Wealth Management held 5 shares of Biogen worth $917 as of Q1 2026.
- Geneos Wealth Management left its Biogen share count unchanged in Q1 2026.
- Biogen made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2417 holding.
- Geneos Wealth Management first reported a position in Biogen in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Biogen position peaked at $1.03M in Q4 2020.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.